mHealth Spot

The company, which will use the new money to expand its team of 20, is working on a wearable metabolic health tracker that should be released in early 2016.

The telehealth service provider plans to offer 7 million shares to the public, each priced between $15 and $17, for a maximum value of $136.85 million.

In sharp contrast, physicians say 38% of patients not using a wearable and 42% of patients not using an app could benefit from doing so.

Users get all of the capabilities the web version has, including e-prescribing to 70,000+ pharmacies and connecting with 550 lab and imaging center partners.

The new money will be used to enter into the research and clinical diagnostics markets, and launch new platforms based on ACD's RNAscope technology.

Moreover, 12% of U.S. broadband households own multiple such devices, according to the latest figures released by Parks Associates.

By combining their clinical and digital strengths, the two parties will provide hospitalists with better tools to collaborate and care for their patients.

The device reduces alarm fatigue by filtering alerts in such a way, that nurses only get notified of alarms triggered by their assigned patients.

Shipment volumes are expected to grow at a CAGR of 42.6% over the five-year forecast period, eventually reaching 155.7 million units shipped in 2019.

Users fill out a profile section to identify their interests and can interact with other people to connect to participate in sports activities together.